Multibic (Sodium Hydrogen Carbonate, Magnesium Chloride Hexahydrate, Sodium Chloride, Calcium Chloride Dihydra)

Sodium hydrogen carbonate provides bicarbonate ions that act as a physiological buffer, helping to neutralise excess acidity in the blood. Together with the other electrolytes, it restores normal plasma pH and contributes to overall electrolyte homeostasis during dialysis or IV therapy.

The dose of Multibic is determined by the prescribing clinician based on the patient’s electrolyte status, fluid requirements, and the specific dialysis protocol. Healthcare professionals calculate the appropriate volume and rate of infusion to achieve the desired therapeutic effect.

Safety data for Multibic in pregnancy and lactation are limited. It should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.

To order Multibic, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and import documentation.

Multibic combines four key electrolytes—sodium, chloride, calcium, and magnesium—in a single sterile solution, offering a broader ion profile than many single‑component preparations. This can simplify fluid management during dialysis, but clinicians should compare individual electrolyte concentrations and compatibility with their specific treatment protocols.

Multibic must be stored at 2‑8 °C in a refrigerator, protected from light. Do not freeze or shake the vial. Before use, inspect the solution for particulate matter or discoloration and allow it to reach room temperature if required for administration.

Multibic is administered intravenously, either as a direct infusion during haemodialysis or as a controlled IV drip in other clinical settings. The infusion rate and total volume are set by the treating physician according to the patient’s electrolyte and fluid needs.

Serious risks include hypercalcemia, hypermagnesemia, severe electrolyte imbalance, and rare anaphylactic reactions. Continuous monitoring of serum electrolytes and cardiac rhythm during infusion helps detect and manage these complications promptly.

Multibic should be avoided in patients with known hypersensitivity to any of its components, in those with uncontrolled hypercalcemia or hypermagnesemia, and in individuals where rapid shifts in electrolyte balance could exacerbate existing cardiac or neurological conditions.